IP Library Granted Patent US 7,749,494
Granted Patent B2
US 7,749,494 · App. 10/275,706 · Granted Jul 6, 2010

Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,749,494
App. No.
10/275,706
Granted
Jul 6, 2010
Kind
B2
Abstract

The invention concerns the use of non-pathogenic hydrogenotrophic acetogenic bacterial strains for preparing a composition for treating or preventing gastrointestinal disorders associated with productions of digestive gases and/or for modulating the microbial balance of the digestive ecosystem in a mammal. The invention also concerns said pharmaceutical or food compositions, and the methods for monitoring and preparing said strains.

Claims (5)

1. A method of treating gastrointestinal disorders related to the production of hydrogen in the gastrointestinal tract in a mammal, the method comprising administering to a mammal in need thereof a composition comprising Ruminococcus hydrogenotrophicus wherein said method does not remove any existing enteric microbial flora prior to administering said composition orally or rectally and wherein said composition modulates the balance of the microbial flora in the colon and reduces the amount of gaseous hydrogen produced by the existing flora.

2. The method of claim 1 , wherein Ruminococcus hydrogenotrophicus remains active in the colon.

3. The method of claim 1 , wherein the composition also comprises a pharmaceutically acceptable carrier.

4. The method of claim 1 , wherein said mammal is human, canine or feline.

5. The method of claim 1 , wherein said gastrointestinal disorder is selected from the group consisting of irritable bowel syndrome, excessive flatulence, meteorism, bloating and abdominal pain.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2023
From: 4D PHARMA PLC; 4D PHARMA RESEARCH LIMITED
To: CJ BIOSCIENCE, INC.
Reel/Frame 063992/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2022
From: OXFORD FINANCE LUXEMBOURG S.A R.L.
To: ARMISTICE CAPITAL MASTER FUND LTD.
Reel/Frame 061806/0371 →
INTELECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 30, 2021
From: 4D PHARMA PLC; 4D PHARMA RESEARCH LIMITED; 4D PHARMA CORK LIMITED; 4D PHARMA DELAWARE INC.
To: OXFORD FINANCE LUXEMBOURG S.A R.L.
Reel/Frame 057042/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: THE MICROBIOTA COMPANY LIMITED
To: 4D PHARMA PLC
Reel/Frame 038333/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2015
From: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
To: GES INVESTMENTS
Reel/Frame 035590/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2015
From: GES INVESTMENTS
To: THE MICROBIOTA COMPANY LIMITED
Reel/Frame 035590/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2008
From: DIGESTAR
To: L'INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
Reel/Frame 020534/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2003
From: RENAUD, MICHEL; BERNALIER, ANNICK
To: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE; DIGESTAR
Reel/Frame 014635/0863 →